EYE vs SOM

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

55MEDIUM

SOM

SOMNOMED FPO [SOM]

55MEDIUM

Score Breakdown

EYE SOM
Technical
38
55
Catalyst
50
53
Sentiment
50
50
Fundamental
63
86
Momentum
60
57
Risk Gate
45
50

Key Metrics

EYE Metric SOM
$37.0MMarket Cap$142.4M
335KAvg Volume (20d)57K
N/AShort InterestN/A
$0.20552-Week High$0.945
$0.08652-Week Low$0.370
-3.8%Daily Change+0.0%
$0.125Entry Price$0.650
-42.4%ROE-5.2%
-21.3%Profit Margin-2.2%

Active Signals

EYE Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Drifting lower — down 3.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Low P/S ratio (1.1x)
Strong revenue growth (+29%)
EPS estimates revised upward (+10pts)

SOM Signals

Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.2x)
Moderate revenue growth (+13%)
EPS estimates revised upward (+10pts)
CANSLIM I: Institutional ownership (58%)

Ask Scout AI to compare EYE and SOM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EYE Full Analysis → SOM Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).